LUND, SWEDEN--(Marketwire - October 24, 2007) - Results of Clinical Phase I Study Presented at US Conference Lund, Sweden, October 24, 2007 - Active Biotech AB (OMX Nordic:ACTI) has presented the final results of the previously reported clinical Phase I study of the cancer project ANYARA in combination with Taxotere® in patients with non-small cell lung cancer.
